PERKINS CAPITAL MANAGEMENT INC - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 177 filers reported holding ANTARES PHARMA INC in Q1 2022. The put-call ratio across all filers is 0.08 and the average weighting 0.1%.

Quarter-by-quarter ownership
PERKINS CAPITAL MANAGEMENT INC ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,974,000
+15.9%
481,483
+0.9%
1.62%
+40.7%
Q4 2021$1,703,000
-13.5%
476,983
-11.8%
1.15%
-5.6%
Q3 2021$1,968,000
-16.7%
540,783
-0.2%
1.22%
-9.1%
Q2 2021$2,362,000
+6.0%
541,783
-0.1%
1.34%
+4.0%
Q1 2021$2,229,000
+16.2%
542,283
+12.8%
1.29%
+2.8%
Q4 2020$1,918,000
+213.4%
480,783
+112.2%
1.25%
+123.1%
Q3 2020$612,000
+11.7%
226,533
-2.4%
0.56%
-15.1%
Q1 2020$548,000
-54.6%
232,166
-9.6%
0.66%
-38.8%
Q4 2019$1,207,000
+19.3%
256,833
-15.1%
1.08%
+24.1%
Q3 2019$1,012,000
-18.0%
302,633
-19.3%
0.87%
+0.9%
Q2 2019$1,234,000
-7.6%
375,000
-15.0%
0.86%
-1.8%
Q1 2019$1,336,000
+20.1%
441,000
+7.8%
0.88%
+2.1%
Q4 2018$1,112,000
-23.9%
409,000
-6.0%
0.86%
-1.8%
Q3 2018$1,462,000
+78.5%
435,000
+37.0%
0.88%
+49.6%
Q2 2018$819,000
+22.8%
317,500
+4.8%
0.59%
-2.3%
Q1 2018$667,000
+33.1%
303,000
+20.2%
0.60%
+24.7%
Q4 2017$501,000
-57.8%
252,000
-31.1%
0.48%
-61.2%
Q3 2017$1,186,000
+3606.2%
366,000
+3560.0%
1.24%
+3451.4%
Q2 2017$32,000
-98.1%
10,000
-98.3%
0.04%
-98.0%
Q1 2017$1,710,000
+20.9%
602,000
-0.8%
1.76%
+13.8%
Q4 2016$1,414,000
+38.6%
607,0000.0%1.55%
+52.0%
Q3 2016$1,020,000607,0001.02%
Other shareholders
ANTARES PHARMA INC shareholders Q1 2022
NameSharesValueWeighting ↓
Healthcare Value Capital, LLC 500,000$2,180,0004.34%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,535,727$11,056,0003.87%
Sargent Investment Group, LLC 3,596,250$15,680,0003.72%
Rubric Capital Management LP 9,500,000$41,420,0002.61%
PERKINS CAPITAL MANAGEMENT INC 541,783$2,362,0001.34%
ORACLE INVESTMENT MANAGEMENT INC 1,900,000$8,284,0001.14%
Venator Capital Management Ltd. 709,700$3,094,0001.05%
LEVEL FOUR FINANCIAL, LLC 120,000$523,0000.22%
OBERWEIS ASSET MANAGEMENT INC/ 200,600$875,0000.19%
Brown Advisory Securities, LLC 275,000$1,199,0000.19%
View complete list of ANTARES PHARMA INC shareholders